707
Views
7
CrossRef citations to date
0
Altmetric
Articles

Integrase Strand Transfer Inhibitors (INSTIs) Resistance Mutations in HIV-1 Infected Turkish Patients

, , , , , , , , , , , , , , , & show all

References

  • Mbisa JL, Martin SA, Cane PA. Patterns of resistance development with integrase inhibitors in HIV. Infect Drug Resist. 2011;4:65–76.
  • Rhee SY, Liu TF, Kiuchi M, Zioni R, Gifford RJ, Holmes SP, et al. Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors. Retrovirology. 2008;5:74. doi:10.1186/1742-4690-5-74.
  • Kulkarni R, Abram ME, McColl DJ, Barnes T, Fordyce MW, Szwarcberg J, et al. Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir df versus atazanavir+ritonavir+emtricitabine/tenofovir df in antiretroviral-naïve patients. HIV Clin Trials. 2014;15:218–230.10.1310/hct1504-218
  • Fantauzzi A, Mezzaroma I. Dolutegravir: Clinical efficacy and role in HIV therapy. Ther Adv Chronic Dis. 2014;5:164–177.10.1177/2040622314530461
  • Vandamme AM, Camacho RJ, Silberstein FC, de Luca A, Palmisano L, Paraskevis D, et al. European recommendations for the clinical use of HIV drug resistance testing: 2011 update. AIDS Rev. 2011;13:77–108.
  • European AIDS Clinical Society (EACS) Guidelines. (2013): Version 7.0, October 2013. www.europeanaidsclinicalsociety.org.
  • British HIV Association guidelines for the treatment of. HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013). HIV Medicine. 2014;15(Suppl. 1):1–85.
  • Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 13 November, 2014. Available at: http://www.aidsinfo.nih.gov.
  • Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 Update. PLoS ONE. 2009;4:e4724.10.1371/journal.pone.0004724
  • Sax P, Islam R, Walensky R, Losina E, Weinstein MC, Goldie SJ, et al. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis. 2005;41:1316–1323.
  • Hacettepe University, HIV/AIDS Treatment and Research Centre. The 2014 Annual Report. http://www.hatam.hacettepe.edu.tr.
  • Sayan M, Willke A, Ozgunes N, Sargin F. HIV-1 subtypes and primary antiretroviral resistance mutations in antiretroviral therapy Naive HIV-1 ınfected ındividuals in Turkey. Jpn J Infect Dis. 2013;66:306–311.10.7883/yoken.66.306
  • Sayan M, Sargin F, Inan D, Yildiz DS, Celikbas AK, Yasar K, et al. HIV-1 transmitted drug resistance mutations in newly diagnosed antiretroviral-naive patients in Turkey. AIDS Res Hum Retro. 2016;32:26–31.10.1089/aid.2015.0110
  • Centers for Disease Control and Prevention. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recomm Rep Dec 1999;10(48):1–27.
  • Casadellà M, van Ham PM, Noguera-Julian M, van Kessel A, Pou C, Hofstra LM, Santos JR, et al. Primary resistance to integrase strand-transfer inhibitors in Europe. J Antimicrob Chemother. 2015;70:2885–2888.10.1093/jac/dkv202
  • Karolin M, Kaveh PY, Sybille S, Stefan F, Barbara B, Max von K, et al Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany. J Int AIDS Soc 2014; 17(Supl 3):19746.
  • Gutierrez C, Novoa BH, Elias MJP, Moreno AM, Holguin A, Dronda F, et al. Prevalence of primary resistance mutations to ıntegrase ınhibitors in treatment-naïve and -experienced patients ınfected with B and non-B HIV-1 variants. HIV Clin Trials. 2013;14:10–16.10.1310/hct1401-10
  • Dimonte S, Mina MB, Aquaro S, Perno CF. Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals. Infection. 2013;41:1097–1102.10.1007/s15010-013-0464-5
  • Eshleman SH, Hudelson SE, Smith P, J Hackett Jr, Holzmayer V, Swanson P, et al. Analysis of pol ıntegrase sequences in diverse HIV type 1 strains using a prototype genotyping assay. AIDS Res Hum Retro. 2009;25:343–345.10.1089/aid.2008.0236
  • Passaes CB, Guimarães ML, Fernandez SL, Lorete RS, Teixeira SL, Fernandez JC, et al. Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil. J Acquir Immune Defic Syndr. 2009;51:7–12.
  • Fish MQ, Hewer R, Wallis CL, Venter WD, Stevens WS, Papathanasopoulos MA. Natural polymorphisms of integrase among HIV type 1-ınfected South African patients. AIDS Res Hum Retro. 2010;26:489–493.10.1089/aid.2009.0249
  • Inan D, Sayan M. Molecular epidemiology of HIV-1 strains in Antalya, Turkey. J Int AIDS Soc 2014; 17(4 Suppl 3):19684.
  • UNHCR official web page. http://www.unhcr.org/pages/49e48e0fa7 f.html
  • Trafficking in human beings report of European Commission. https://ec.europa.eu/anti-trafficking

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.